Advancing Care in Intra-Abdominal Candidiasis: Exploring the Potential of Rezafungin

/in ,

Tuesday, December 8, 2026 (2:00 pm – 3:00 pm EST)

This webinar explores the challenges of managing intra-abdominal candidiasis (IAC) and the potential role of rezafungin. Designed for surgeons and other healthcare professionals, the session reviews current treatment recommendations, emerging clinical evidence, and considerations for transitioning patients from hospital to outpatient care.

Participants will gain insights to help them:

  • Recognize the clinical burden of IAC and key risk factors in critically ill patients.
  • Understand guideline recommendations for antifungal therapy, including the role of echinocandins and the importance of source control.
  • Evaluate the evidence for rezafungin, including findings from STRIVE and ReSTORE and emerging data specific to intra-abdominal infections.
  • Explore how once-weekly therapy may support transitions of care.

 

     

    Speakers

    Luis Ostrosky-Zeichner
    MD, FACP, FIDSA, FSHEA, FECMM, CMQ
    UTHealth Houston
    ID Physician

     

     

     

    Jared M. Huston
    MD, FACS, FSIS, SMNAI
    Northwell Health

     

     
    2026 Presidential Address